The Effect of Aromatherapy Applied After Cesarean Section on Pain Intensity and Comfort Level

October 25, 2023 updated by: Hafize Dağ Tüzmen, KTO Karatay University

Determination of the Effect of Aromatherapy Using Lavender and Ylang Ylang Essential Oils on Pain Severity and Comfort Level After Cesarean Section: A Randomized Controlled Study

Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Oils can be applied directly to a single person or indirectly to people in a room by inhalation . In direct application without steam, essential oils can be applied by inhalation by dripping onto a cotton ball . It is stated that lavender aromatherapy, one of the most commonly used aromatherapies, has analgesic, antiseptic, sedative, antispasmodic and healing properties Ylang Ylang aromatherapy is stated analgesic, anti-inflammatory, antimicrobial, antiemetic,anti-tarral, carminative, sedative, antiseptic, spasmolytic properties. In the studies conducted, anxiety, labor pain, labor duration, and psychological effects of aromatherapy were examined, but no study was found in which lavender and chamomile essential oils were used and the effects of pain and comfort level were examined. The aim of this study is to determine the effect of lavender and Ylang Ylang essential oils in relieving pain and increasing comfort after cesarean section.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Konya, Turkey, 42000
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-49 years old,
  • women who have had a cesarean section

Exclusion Criteria:

  • epilepsy,
  • migraine,
  • chronic headache,
  • asthma,
  • women who are allergic to fragrance sensitivities to aromatic oils

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
No intervention
Active Comparator: Ylang Ylang oil Group
GROUP 1
Other: Ylang Ylang oil with inhalation
Ylang Ylang OIL WILL BE INHALED
Active Comparator: Lavender oil
GROUP 2
Other: Lavender oil with inhalation
LAVENDER OIL WILL BE INHALED

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain related to cesarean section
Time Frame: post operative 4-8-12 hours
It will be measured with Visual Analog Scale. Visual Analog Scale has a rating between 0-10. The higher the score, the greater the pain.
post operative 4-8-12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comfort related to cesarean section
Time Frame: post operative 4-8-12 hours
Comfort will be measured with the postpartum comfort scale. The higher the score, the higher the comfort level.
post operative 4-8-12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KTO Karatay University

Collaborators

ŞERİFE İREM DÖNER
Merve YAZAR
JULE ERİÇ HORASANLI

Investigators

  • Study Chair: MERVE YAZAR, merve.yazar@karatay.edu.tr
  • Study Chair: şerife irem döner, serifeiremdoner@gmail.com

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2023

Primary Completion (Actual)

August 17, 2023

Study Completion (Actual)

October 25, 2023

Study Registration Dates

First Submitted

April 18, 2023

First Submitted That Met QC Criteria

August 23, 2023

First Posted (Actual)

August 24, 2023

Study Record Updates

Last Update Posted (Actual)

October 26, 2023

Last Update Submitted That Met QC Criteria

October 25, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Aromatherapy Group

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section Complications

Clinical Trials on Ylang Ylang oil with inhalation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe